INTRAHEPATIC CHOLANGIOCARCINOMA
Clinical trials for INTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new INTRAHEPATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for INTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Virus therapy shows promise for tough bile duct cancer in early trial
Disease control Not yet recruitingThis study tests a new treatment called VG2025 for people with advanced intrahepatic cholangiocarcinoma, a type of bile duct cancer that has spread. The treatment uses a modified virus to target and attack cancer cells. About 30 adults aged 18 to 75 will receive the therapy to se…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Virogin Biotech Ltd. • Aim: Disease control
Last updated May 26, 2026 04:16 UTC
-
New hope for advanced bile duct cancer: triple therapy trial launches
Disease control Not yet recruitingThis study tests a new combination of drugs for people with advanced intrahepatic cholangiocarcinoma (a type of bile duct cancer) that cannot be removed by surgery. The treatment includes chemotherapy delivered directly to the liver, a targeted oral drug, and an immunotherapy. Th…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 26, 2026 03:55 UTC